expressed mRNAs with independent observations of 3, 8, and 3, respectively (24, 27, 40) .
However, none of these reports provided valid statistical analyses to identify significant differences nor did they estimate the percentage of false positives in their lists of differentially expressed transcripts. Thus for the current experiment, it was reasoned that the use of larger sample sizes would allow greater statistical power so that conservative statistical adjustments could be made to minimize the presence of false positives. The purpose of the current experiment was to develop a statistically conservative list of genes whose expression differed significantly between young growing and old-sarcopenic muscles, which may be contributing to physical frailty. The hypothesis of the current study was that a subpopulation of growth factor mRNAs would be downregulated in old skeletal muscle, associated with old muscle no longer growing.
Materials and Methods
Animals. Fischer 344 x Brown Norway F l male rats obtained from the National Institute on Aging (Harlan Labs, Indianapolis, IN) and were sacrificed at the ages of 3-4-months (young, N = 25) and 30-31 months (old, N = 20) . These ages were selected on the basis of previous data (8) . They received regular rat chow and water ad libitum, were housed 2-3 per cage, and maintained on a 12:12 hour light-dark cycle. Prior to muscle extraction, animals were anesthetized with an intraperitoneal injection of a cocktail containing ketamine (49 mg/mL), xylazine (6.2 mg/mL), and acepromazine (2.0 mg/mL) at a concentration of 0.123 mL/100mg body weight. Soleus muscles were excised, weighed, snap-frozen in liquid nitrogen, and subsequently powdered using a mortar and pestle cooled by liquid nitrogen. Both soleus Sample processing for microarray analysis. Total RNA was isolated from an aliquot of muscle powder that was put directly into a TRIzol solution (Invitrogen) and homogenized on ice using a Polytron homogenizer (Kinematica) on setting 7 for three pulses 15 seconds each.
The total RNA was further purified using RNeasy columns (Qiagen). Methods for sample preparation are described in detail in the Affymetrix Expression Analysis Technical Manual (Santa Clara, CA) and are briefly described next. Ten micrograms of purified total RNA was put into the cDNA synthesis reactions with a T7-(dT) 24 primer (100 pmol/uL). First and second strand cDNA synthesis were carried out using components of the Superscript Choice kit (Invitrogen) with all incubations done in a Mastercycler Gradient thermocycler (Eppendorf).
The amount of resulting double stranded cDNA was quantified using a PicoGreen kit (Molecular Probes). One microgram of cDNA was added to the in vitro transcription reaction utilizing biotinylated nucleotides provided in the BioArray High Yield RNA Transcript Labeling Kits (Enzo Diagnostics, Inc.). The resulting cRNA was further purified using RNeasy columns (Qiagen). The purified biotinylated cRNA was then fragmented and subsequently hybridized to Affymetrix rat genome U34A, B, and C arrays and analyzed by fluorescent intensity scanning according to Affymetrix protocols (Affymetrix Expression Analysis Technical Manual). The hybridization and scanning of the arrays was performed in the University of Missouri DNA Core Facility (Columbia, MO).
U34 micoarrays.
The U34 arrays were created in 1998. At that time the array set was FINAL ACCEPTED VERSION PG-40- 2003R1 7 estimated to contain ~7000 full-length/annotated genes based on Unigene Build 34, which were all located on the A chip. Similarly, the remaining probe sets assayed for >17,000 ESTs, predominantly located on the B and C arrays. However, since that time many advances have been made to allow a considerable number of the ESTs to be identified. The human genome has been completed. The mouse genome is now available as a draft that is 95% complete. The rat genome project has begun and is projected to be finished before the year's end. Now in 2002, many of the ESTs previously unassociated with known genes now are sufficiently homologous, such that "as of Unigene build 99 over 28,000 well substantiated genes exist" (Affymetrix technical datasheet rat230). Thus, many of the ESTs available on the B and C arrays can now be substantiated as 'true genes' based on their significant homologies to the known genes identified in the mouse and human genomes. The U34 array set assays ~24,000 genes and ESTs, represented by 26,379 probe sets. Thus, some mRNAs are assayed by multiple probe sets. Also, some ESTs have since been identified as portions of full length/known genes, where the ESTs are known to be part of same Unigene cluster as the full-length mRNAs causing multiple probe sets to assay the abundance of a single mRNA.
GeneChip® analysis.
Each probe set consisted of sixteen perfectly matched (complementary) 25-mers, corresponding to different regions along the length of a transcript.
Likewise, sixteen mismatched pairs (containing a single mutated base) that do not perfectly complement a mRNA's sequence were used as a measure of non-specific background binding.
The Microarray Suite 5.0 software (Affymetrix) was employed which uses a one-sided Wilcoxon's signed rank test to calculate a p-value reflecting the significance of differences between the perfectly matched and mismatched probe pairs, based on their fluorescent FINAL ACCEPTED VERSION PG-40- 2003R1 8 intensities. The resulting p-values were used as a qualitative assessment of the ability to detect a given transcript, where p-values <0.04 were called "Present", p-values between 0.04-0.06 were called "Marginal" and p-values >0.06 were called "Absent". Only probe sets that were "Present or Marginal" in 60% of the samples for an experimental group were analyzed statistically, with 11,165 probe sets sufficiently detected in at least one of the two experimental groups: i.e., young or old soleus muscles. ~20% of the 682 significantly different probe sets contained probe sets with more than one "Absent" call within the 20-25 muscle samples composing an experimental group (Supplemental Table 1 ). Approximately 4%-9% of the 682 probe sets were consistently called absent in only one of the two experimental groups, implying turning "on" or "off" of mRNA expression. Microarray Suite 5.0 software (Affymetrix) uses statistically-based algorithms to determine transcript abundance based on fluorescent intensities (termed "signal").
The "signal" for each probe set was calculated as the one-step biweight estimate of the combined differences of all of the probe pairs in the probe set. We used the calculated signal value for all subsequent statistical analyses. The fold changes of 347 probe sets that increased in the older group, relative to the young were calculated as the mean old signal intensity/mean young signal intensity. The fold changes of the 335 probe sets that decreased in sarcopenic muscle were determined as the mean young signal intensity/mean old signal intensity. A fold change of a certain magnitude can be converted to a percentage decrease by
Microarray data analyses have been criticized as being "quite elusive about measurement reproducibility" (9) . However, Bakay et al. (2) h t t p : / / w w w . a f f y m e t r i x . c o m / a n a l y s i s / q u e r y / i n t e r a c t i v e _ q u e r y , http://www.incyte.com/proteome/databases). A gene's biological processes and molecular functions were determined based on the defined gene ontologies given in the aforementioned databases. Raw data from the current experiment are available at the GEO database, in a MIAME compliant format.
The accession numbers to retrieve this data are listed in Supplemental Table 2 .
Real-time PCR sample preparation. Total RNA was DNase-treated using RNase-free DNase set (Qiagen), which was then purified over a RNeasy column (Qiagen). The absence of Real-time PCR analysis. Differences in gene expression were calculated using relative quantitation to18S rRNA, via the comparative C T method, according the User Bulletin #2 ABI PRISM 7700 Sequence Detection System. 18S rRNA was confirmed as an appropriate normalizer by comparing the differences in raw C T 's. 18S rRNA expression did not differ with age (p=0.55).
Relative efficiency plots were run to validate use of the C T method, where all slopes were <0.1.
The differences in C T 's for young and old were analyzed with the Student's t-test with p<0.05 set as significant. Data are expressed as the calculated-fold differences between young and old, with actual p-values. Assay order for real-time PCR began at a 2-fold difference from microarray analysis, and then progressively lowered the fold differences (starting with ~2.0 for atrogin, theñ 1.8 for IGFBP3, then ~1.7 homer2, then ~1.6 elfin, then ~1.4 prolyl-4-hydroxylase, and finallỹ
for agrin).

Results
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Fischer 344 x Brown Norway F 1 rats have previously been shown to be growing through 3-4 months of age, which corresponds to the ages of the young rats used in the current experiment (36).
Rats were sacrificed in sets of N=5 over a 30-day period on days 0, 3, 6, 10, and 30. The soleus muscle mass of rats sacrificed on days 0 and 3 were compared to those sacrificed on day 30. There was a trend towards increasing soleus muscle mass, 15% increase (0.129 ± 0.005 to 0.149 ± 0.008) in the young rats over the course of the experiment (p=0.062). Conversely, over a 30-day period, the soleus muscle mass decreased 10% (0.174 ± 0.003 to 0.156 ± 0.003) in the old rats (p=0.002).
Using an = 0.05, with a Bonferroni adjustment on 11,165 statistical tests, gave a p 4.478x10 -6 for significant differences. 682 probe sets had significant differences between young growing and old, sarcopenic groups. Of the identified probe sets, 347 decreased and 335 increased in the old relative to the young (Supplemental Tables 4 and 5 ). Statistical power analysis showed that even with a significance level as low as 5x10 -6 , a sample size of 20 independent observations per group was sufficient (power 80%) to detect a 1.4-fold difference, assuming a 20% coefficient of variation, i.e., assuming / =.20.
As an exercise to demonstrate the importance of sample size in finding significant differences, subsamples of data were examined. Subsets of 5x5, 10x10, and 15x15 that had been randomly selected from the 25x20 sample were evaluated with a recursive analysis, where each sample size was randomly assembled and analyzed twenty different times to better estimate the expected number of significant changes that occur with the smaller sample sizes (Supplemental Table 6 ). For one comparison, 15 samples were selected with a random number generator from both the young and old groups and the same procedures as described above were used to determine how many probe sets would have significant differences. In this case, 331 probe sets were identified as FINAL ACCEPTED VERSION PG-40-2003R1 13 significantly different as compared to the 682 found using the full set of data (20x25). When sets of 10 samples were randomly selected, the number of probe sets showing significant differences dropped to 73 and the number dropped to only 3 significant probe set when sets of 5 samples were randomly selected (Supplemental Table 6 ). Note, that if other subsamples were randomly selected for the smaller sized groups: 5, 10, and 15, the number of observed probe sets with significant differences would not be exactly the same, but would be of similar order of magnitude.
Furthermore, there is a decreased probability of accepting lower fold changes as significant when sample size is decreased (Supplemental Table 7A ). Similarly, there is a decreased probability of accepting larger variations at a given fold change as significant when the sample size is decreased (Supplemental Table 7B ).
In the comparison of 20 x 25, 412 probe sets were identified which corresponded to known genes or had homologies to known genes that were significantly altered between young growing and old sarcopenic muscles. Some of the known genes could be assembled into functional groups with common themes. For example, 20 (9%) of the 213 identifiable genes that were increased in the old soleus muscle had functional commonalities to transcripts with roles in protein degradative processes including proteolysis and ubiquitin-based degradation; 29 (14%) to immune functions; and 15 (7%) to stress/antioxidant (Fig. 1) . Of 347 total decreases in mRNA in the old soleus muscle, 199 were functionally identified; the major theme being that 48 (24%) had a biological role in the extracellular matrix (ECM) and cell adhesion ( Table 8 ). Using Fisher's Exact test on the current significant data extend the previous observations of increases in proteolytic genes, as well as genes related to stress, defense, and immune responses (24, 27, 40) to show that the aforementioned functional categories were disproportionately regulated in soleus muscles of 30-mo-old rats (p<0.0001) among their categories on the micorarrays. Probe sets in other functional categories (growth factors, ubiquitin-dependent degradation, signal transduction, metabolism, and phosphorylation) were not significantly altered with age (p>0.05).
A comparison of microarray and real-time PCR analyses of the same RNA samples was performed on a subset of differentially expressed targets (Table 1) . With microarray analysis, all fold changes -1.58 were confirmed with real time PCR (Table 1) . However, statistical significance [-1.36 fold (a 26% decrease)] was not reached for agrin mRNA with real-time PCR analysis on the same RNA samples (Table 1) . Interestingly, prolyl-4-hydroxylase mRNA, which had a significant -1.34 fold (a 25% decrease) with microarray analysis was validated as a significant difference with real-time PCR. This demonstrates that low-fold changes can be validated as significantly different.
One potential reason for failing to reproduce a significant change for agrin, might be due to the fact that the levels of some genes differ between mRNA and total RNA, where a significant difference is apparent from an mRNA population, as employed on the microarray, but not in total RNA used for real-time PCR. Strikingly, the proportions of functionally related probe sets differed between mRNAs showing < and > 2-fold significant changes (Fig. 1) . The increased sample size used in the current experiment yielded hundreds of significant differences, confirming an established mathematical principle of power, that is; as the number of observations increases, the ability to detect differences of a given level will be increased. Tables 7A and 7B ). Use of smaller sample sizes was associated with fewer significant differences between young and old due to a failure to find probe sets with larger variation or smaller fold changes significant (Supplemental tables 7A and 7B).
Conservatism in minimizing false
Determination of appropriate sample size will be dependent upon a given data set or treatment, so the information on sample size and fold change is specific only for the current data set and would only be directly applicable for other aging muscle studies. Other treatments will have different effect sizes and will cause differing numbers of genes to be differentially expressed.
Others have emphasized the importance of using statistical approaches in microarray experiments. For example, Kerr and Churchill (25) wrote that one cannot consider just the genes with large-fold changes in expression that are obvious to detect without the aid of statistics because this practice overlooks important genes that may have small, but reproducible, changes in expression. Also many genes with large-fold changes in expression may not be significantly different (See below). Wolfinger et al. (41) contend that simple rules that eliminate genes with less than 2-or 3-fold expression changes will miss very biologically important genes that have a smallfold change, but which are highly significant because they can be measured with high precision as a result of replication. The histogram of fold change distributions (Fig. 2) shows that use of a 2-fold cutoff for mRNA identification in the current experiment would have only identified 12% of the 347
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significant decreases and 20% of the 335 significant increases with fold changes (Fig.2) to state that gene expression patterns in skeletal muscle seem to be remarkably stable during the adult mammalian life span, a finding that they interpreted as in contrast with the hypothesis that aging is due to large and widespread alterations in gene expression. Employing a large sample size yields a more global set of results, better suiting a global technology, like microarrays.
Next, real-time PCR was employed to validate a subset of differentially expressed targets generated from microarray analysis on the same RNA samples. Usage of real-time PCR verified a fold change down to -1.34 (25% decrease of old compared to young), but a -1.36 fold change for agrin mRNA was not confirmed, suggesting that lower-fold changes found with microarrays have a lower probability of being corroborated. The failure to reproduce significant differences found will have sufficient power with sample sizes less than 20, whereas other studies where treatments affect fewer changes in gene expression will likely require sample sizes larger than 20.
Gene Expression Changes in Young and Old Skeletal Muscle. One unexpected advantage
of using a large sample size was that in addition to more genes being identified with significant differences was that it allowed for the identification of differentially expressed functional families.
Aged skeletal muscle has been previously shown have a selective up-regulation of transcripts involved in inflammation and oxidative stress, and a down-regulation of genes involved in mitochondrial electron transport and oxidative phosphorylation (24, 27) . Since ~30% of the increases in mRNA and ~1% of the decreases that occurred in the old soleus muscle were related to immune, defense, and stress functions (Fig. 1) , a question for future research was raised as to whether these processes have some sequential order of appearance in order to establish cause and effect. For example, does degradation precede or follow immune, defense, and oxidative stress increases? One EST of interest was homologous to mouse F-box protein 32 (atrogin) mRNA.
Atrogin-1, an ubiquitin-protein ligase (E3), appears to be a critical component in the enhanced proteolysis leading to muscle atrophy (18). The probe set was 1.96-fold higher in the old soleus muscle; however, the magnitude of this increase was less than that found in other examples of muscle atrophy. A 9-10-fold increase in atrogin mRNA occurred in the gastrocnemius muscle of young rats experiencing one of the following treatments: fasting, streptozotocin-induced diabetes, aforementioned conditions may be associated with the slower rate of muscular atrophy that occurs in sarcopenia.
The major theme of the decreasing mRNAs in the old soleus muscle was 48 probe sets featuring a biological role in the ECM and cell adhesion (Fig. 1) . On the other hand only 3 transcripts with an ECM or cell adhesion function increased. These data extend the earlier observations of an age-related decline of procollagen I and III mRNA expression in mice and humans (16, 27, 40) , which Goldspink et al. (16) interpreted to strongly suggest that the increased fibrosis of skeletal muscle with age is not the result of increased collagen gene expression but is most likely due to an impairment of degradation. Muscle inactivity has previously been associated with a downregulation of three extracellular-related mRNAs (laminin B2 chain, pro 1 collagen type III, and actin-binding protein 280) (10) . As the old rats in the current study were less physically active (22), we speculate that decreased mechanical loading of the old soleus muscle may contribute to its downregulation of ECM transcripts. Indeed, in old muscle as compared to young, repair of old skeletal muscle is slower (19) and regrowth from atrophy is often absent (8) . Collagen XV is a major component of various basement membranes and two ESTs similar to mouse collagen XV were found to be 1.75-and 1.55-fold lower in the old, than the young, soleus muscle (Supplemental Table 3 ). Mice null for collagen XV by three months of age show progressive histological changes that are characteristic of muscular diseases, and are more vulnerable than controls to exercise-induced muscle injury (12). Eklund et al. (12) suggested that the prominent changes seen in the collagen type XV-deficient muscle fibers could reflect a defect in linkage between the muscle cell basement membrane and the surrounding fibrillar matrix. As old skeletal muscle is more susceptible to contraction-induced injury (6), it is reasonable to hypothesize that reductions in collagen XV in old muscle could contribute to its increased susceptibility to injury.
Aging skeletal muscle demonstrates an increased number of extrajunctional receptors (33) and spontaneously denervated muscle fibers (29) . Indeed , , , and subunits of the acetylcholine receptor (AchR) increased 4.94-, 1.64-, 2.71-and 1.56-fold, respectively, in the old soleus muscle as compared to young (Supplemental Table 4 ), similar to increases found by others, suggestive of transient denervation (17, 33) . In addition, a previous study found that in 30-mo-old mouse muscle, genes involved in neuronal growth accounted for 9% (5/58) of genes highly induced in old muscle (27) . Thus, the increased neuronally-related mRNAs in old muscles allows the generation of a hypothesis that AchR gene expression reflects spontaneous denervation of old FINAL ACCEPTED VERSION PG-40- 2003R1 23 muscle fibers, and the eventual loss of muscle fibers. Another neural mRNA, previously unidentified as differentially expressed, was -synuclein which was 5.28-fold higher in the old than young, soleus muscle (Supplemental Table 4 ). -synuclein is expressed in the brain and spinal cord, but is most abundant in the peripheral nervous system and may play a mechanistic role in the onset or progression of several neurodegenerative disorders (14) . Insoluble -synuclein filaments accumulate intracellularly in brains of patients with Parkinson disease and dementia with Lewy bodies (14) . As motor neurons to skeletal muscle are lost with aging resulting in the disappearance of entire motor units (13), the increased -synuclein mRNA in the old soleus muscle provides a hint for a potential candidate to explain this defect in sarcopenic muscle.
Follistatin is an extracellular factor that binds and modulates activin and myostatin activity (28) . Follistatin mRNA was 3-fold higher in old sarcopenic muscle. As overexpression of follistatin has been shown to double muscle mass (28) , speculation can be made that follistatin is acting as an insufficient compensatory response to sarcopenia. Follistatin may fail to prevent the atrophy in old muscle because downstream regulation is defective either with follistatin translation, or in subsequent follistatin-induced signaling. Interestingly, a follistatin-like (FS) domain is found in the matricellular protein, Sparc (also called osteonectin or BM-40) (20) . FS domains derive their name from a cysteine-rich domain repeated three times in the follistatin protein. Sparc is one of the handful of ECM proteins that have been conserved from worm to man, but while it's biological functions are still largely unknown, it binds with moderately high affinity to collagens I-V (See 20 for refs.). Sparc mRNA also decreased ~3-fold in the old soleus muscle (Supplemental Table 3 ).
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As expected, for post-mitotic muscle, few genes involved in the regulation of cell cycle were observed as significantly different with age. Also of interest, two genes involved in myogenic differentiation, MyoD and myogenin were differentially increased in sarcopenia compared to young growing muscle (+3.35 and +1.45, respectively). These mRNA data support the previous findings that MyoD and myogenin protein levels were elevated in senile muscle. Dedkov, et al., suggested that the elevated MyoD and myogenin levels were the result of "partial or complete denervation and participation of satellite cells in compensatory myogenesis" (11).
IGFBP-5 mRNA was recently found to decrease in fasting muscle, which was interpreted to favor the atrophy process (18), but was found to be twice as high in old as young soleus muscle (Supplemental Table 4 ). In a previous experiment (34), we confirmed that IGFBP-5 mRNA, assayed by RT-PCR, doubled in the old soleus muscle, but that IGFBP-5 protein was decreased by one-half. These data support the postulate that a "thermostat-like" mechanism which senses the loss of mass in old skeletal muscle upregulates numerous mRNAs to attempt to rescue muscle from sarcopenia, but that the expression and translation of other necessary factors are deficient and/or unresponsive in the old muscle. The ESTs with unknown functions identified in the present study are candidates for both the "thermostat-like sensors" detecting mass, as well as the deficient factors limiting sarcopenic muscle's ability to maintain its pre-atrophy size.
The hypothesis of the current study that a subpopulation of growth factor mRNAs would be downregulated in old skeletal muscle was thus not upheld (Supplemental Table 8 ). However, the failure to find a disproportionate expression of growth factors genes should not be interpreted to mean that these are unimportant in the old soleus muscle, because changes in only a few of these could trigger sarcopenia, and thus a disproportional change in growth factors was not significant.
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Gill et al. (15) contend that interventions designed to prevent functional decline into physical frailty have the potential not only to generate large health care savings, but also to lead to important reductions in the physical, emotional, social, and financial problems attributable to disability. As a previous study showed that the overexpression of IGF-I could ameliorate muscle wasting in older mice (3), knowledge of other genes responsible for sarcopenia could become clinically significant.
Although changes in growth factor and signaling mRNAs were not the most predominant alterations 
